Nxera Pharma Co (TSE:4565) Total Operating Expense: 円29,880 Mil (TTM As of Mar. 2026)


TSE:4565 Nxera Pharma Co Ltd TSE:4565
72 GF Score
Price 円919.00
GF Value 円1,331.72
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co Total Operating Expense?

Nxera Pharma Co TSE:4565 +2.11% 72 Total Operating Expense is 円29,880 Mil as of Mar. 2026. GuruFocus rates TSE:4565 with a GF Score™ of 72/100 and a GF Value™ of 円1,331.72 (Possible Value Trap). The stock has 7 warning signs investors should review.

Nxera Pharma Co's Total Operating Expense for the three months ended in Mar. 2026 was 円7,222 Mil. Nxera Pharma Co's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円29,880 Mil.

Nxera Pharma Co Total Operating Expense Related Terms

Nxera Pharma Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Total Operating Expense Chart

Nxera Pharma Co Annual Data
Trend Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,004.00 11,207.00 19,190.00 26,642.00 29,880.00

Nxera Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,222.00 7,155.00 7,232.00 8,271.00 7,222.00
TSE:4565
72GF Score
Nxera Pharma Co Ltd TSE:4565
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nxera Pharma Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円29,880 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of 円29,880 Mil mean?
Nxera Pharma Co (TSE:4565) has a Total Operating Expense of 円29,880 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nxera Pharma Co and its competitors.
Is Nxera Pharma Co's Total Operating Expense too high?
Nxera Pharma Co's current Total Operating Expense is 円29,880 Mil. Overall, Nxera Pharma Co has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Total Operating Expense compare to VRTX and REGN?
Nxera Pharma Co's Total Operating Expense of 円29,880 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current Total Operating Expense is 円29,880 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Nxera Pharma Co (TSE:4565) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,331.72, compared to a current price of 円919.00 — trading 31% below its estimated fair value. The current Total Operating Expense is 円29,880 Mil. Nxera Pharma Co's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Nxera Pharma Co (TSE:4565), the current Total Operating Expense is 円29,880 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of 円919.00 is trading 31% below its estimated GF Value™ of 円1,331.72. GuruFocus considers Nxera Pharma Co to be Possible Value Trap.

Key valuation signals for TSE:4565:

  • Total Operating Expense: 円29,880 Mil
  • GF Value™: 円1,331.72 vs. price of 円919.00 (31% below fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
72GF Score

Get the complete analysis for TSE:4565

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円919.00
Price
円1,331.72
GF Value